Ritgovi Tablets 4mg, from Taiho Pharmaceutical, contains Futibatinib (YJ code: 4291080F1029, standard: 4mg 1 tablet). This medication is a selective and irreversible inhibitor of fibroblast growth factor receptor (FGFR) 1, 2, 3, and 4. It is used for the treatment of previously treated, unresectable, locally advanced or metastatic intrahepatic cholangiocarcinoma harboring FGFR2 gene fusions or other rearrangements.
Ritgovi Tablets 4mg
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).